Effect of N-Acetyl Cysteine (NAC) on the Oral Microbiome

Phase 2 Withdrawn Wake Forest University Health Sciences National Cancer Institute (NCI) · collab

RandomizedParallel-groupOpen-labelSupportive care

Summary

This is a Phase II treatment, randomized 3:1 ratio, open label clinical trial to study the effect of short duration administration of N-acetyl cysteine on oral microbiome and on mucositis caused by concurrent chemotherapy and radiotherapy.

Timeline

Start: 2020-06-18
Primary completion: 2020-06-18
Completion: 2020-06-18

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	N-acetylcysteine	Small molecule	600 mg	—

Effect of N-Acetyl Cysteine (NAC) on the Oral Microbiome

Summary

Timeline

Drugs

Indications